|
New “Smart Drug” Unleashes Holy Hell on Nature’s Deadliest Disease Its “Warrior Antibodies” could save 7.6 million people…
Maryland company… Here’s how…
At a small lab 35 miles north of Washington, D.C., scientists have made a discovery – one that could save the lives of 7.6 million people a year! Not the Salk vaccine… nor penicillin… nor even open-heart surgery can compare to the life-saving potential of this revolutionary new drug. The breakthrough I’m talking about is a “smart” drug, made possible by the advances from the Human Genome Project. You see, this new drug treatment unleashes holy hell on cancer. And it does so with more savage effectiveness than anything in use today. Imagine for a moment, that you could flip a switch and turn your own cells into the strongest… meanest… tumor-killing machines in existence… And that once turned on, your very own “warrior cells” would literally “seek” and then “destroy” the disease better than any known drug in existence. And what if you could make those “warrior cells” clone themselves and evolve, just like the cancer does… following, detecting and blasting – in lockstep – every hideous trace of cancer from existence? This is not science fiction… It’s exactly how this new drug treatment works – every single miraculous step. You see, we’ve been following the breakthrough for over two years now. And the success rate is astounding! In one study, nearly four out of five patients have been left free of the disease following treatment… even after 12 other regimens failed. And it works with no harmful side effects… no pain… and no debilitating sickness that comes from chemo and radiation. For millions of people, it stands to be nothing short of a miracle. Scientific journals are now reporting that this treatment “attacks late stage cancer,” and is “safe and effective, even at relatively low doses.” Another article says: When this “smart drug” is released into the bloodstream, it “not only summon[s] the immune cells to attack the cancer, [it] also stimulate[s] the body to produce more of the cells, thus replenishing its armies.” The company that invented this new drug technology is small. It has a market cap just over $500 million. We estimate that this small company’s stock price is poised to gap up by as much as 2,000%, perhaps starting in a matter of days and weeks. It’s trading around $7 a share today. That means it’s cheap as can be – and with enough shares to go around. But please know this… After the news breaks in the media, there will be no scraps left for the latecomer. That’s why we’re sharing this information with you now after two years of research. When it comes to a breakthrough like this, timing is everything. Here’s exactly how we expect this situation to play out.
Small Leaks… Then a Flood of Massive Gains… In the coming days and weeks, we expect you’ll start hearing the news about this revolutionary treatment. Media reports about a remarkable new cancer-fighting drug (we call it PCD for Programmed Cell Destruction) will build in frequency, until it appears on “60 Minutes.” But you’ll already know about it well in advance. And the gains? Get ready. Here’s how they size up…
Early investors were jubilant. And they had a right to be. Yet the potential gains on this little Maryland company could make those triple-baggers look like small change. That’s because battling cancer is big business. On average, $10,000 is spent on treating each cancer patient. And there are more than 12 million patients in the U.S. alone. All told, it’s a $120 billion industry… Only “Big Oil” makes more money. And (unfortunately), the market for cancer treatment is growing at a rapid pace. And not just here in the U.S., but around the world. Just this past June, the International Agency for Research on Cancer predicted that almost 22 million new cases of the disease will be diagnosed annually by 2030. When you look at the dollars being spent today, the effects of this are staggering. In 2009, the four biggest cancer-fighting drugs just by themselves exceeded $15 billion in sales.
But here’s what most people don’t know… Now listen up. I’m going to say this loudly:
These multi-billion dollar drugs have very limited medical success! According to Steven Rosenberg, chief of surgery at the National Cancer Institute, no less…
“While these drugs are a big business for companies, most have Yet unlike the “single-cancer” medications above, the unique technology behind PCD could be harnessed to help treat virtually every type of cancer… and with unprecedented effectiveness. It has the potential to hand early-in investors over 20 times their money. Enough to turn a small stake into $50,000… $100,000… even $400,000 in the short run. But only if you act now. The timing for large gains is critical. In fact, we’ve been waiting for this moment for quite a long while…
Over 2 Years in the Making…
Our team of analysts didn’t start out as medical experts. We don’t have Ph.Ds in microbiology or genetics. What we do have is this: A combined 87 years of hands-on research and experience helping folks make some very large amounts of money. And the proof to back it up, as you’ll see below. I’m talking about the kind of money you can get when you’re among the first to invest in the telecom boom… Or the tech boom… Or the commodity boom… We’re constantly scanning the globe for little-known companies that are poised to break out. And we’ll travel from San Francisco to Singapore, from Rio to Reykjavik to find them. We first spotted the company behind PCD in late 2008, when one of our own researchers – with a personal interest in cancer treatment – mentioned some amazing work being done outside of Washington. This company’s promising technology jumped out at us immediately. We knew we had to keep our eye on it. And we did. Day by day… Week by week… Year by year. It started with small mentions in peer-reviewed journals and presentations at scientific conferences. We followed it through FDA trial stage 1… And FDA trial stage 2…
In one test, the goal was to reduce cancer cells to undetectable levels in 22% of the patients. Instead, 80% of the patients had no detectable cancer cells at the end of the first treatment cycle. But still, we watched… and waited… patiently… Now, the company that makes PCD is in the sweet spot, ready to break out like a champagne cork. We believe that time is now. Already the company is in discussions on collaborative partnerships and licensing agreements with no less than five major pharmaceutical companies. The scientific and medical community is electrified. And it’s no wonder. This miraculous breakthrough…
It’s the three-step process that defeats the deadliest disease known to man. It works so effectively with the human body that some scientists describe it as “rapturous.”
Step One: PCD makes the body’s own T-cells (the most powerful, natural cancer killers), find the cancer cells. And then it actually makes these T-cells LINK ON to them. This has never been done before. You see, cancer cells are extremely “clever.” It’s why they’re so deadly. They can recognize attacks like these and generate “self-defense” chemicals that let them elude T-cells – and even begin multiplying to outnumber them! This has been the downfall in most cancer therapies to date. But no more. You see, thanks to PCD, these T-cells are made to “lock on” in a new way… a way that the cancer cell simply doesn’t recognize – and thus can’t defend against. The scientists at the Maryland lab call it a “cytolytic synapse”… but you can just think of it as a cancer-destroying Warrior.
Step Two: Cancer-killing agents are released that literally punch holes right into the tumor cell.
That’s followed by an assault of natural T-cell proteins that create the “programmed cell death.” At this stage, tumors are destroyed. Without chemo, radiation or side effects. And yet, the next stage is even more amazing… Step Three: As soon as the destruction of one cancer cell is underway, the Warrior cell breaks away and moves to the nearest adjacent cancer cell, where it strikes again! Throughout the killing process, the body’s own T-cells start to proliferate. This leads to an increased number of cancer-killing T-cells at the site of attack.
The tumor area soon has an ever-growing army of cancer-killing “Warrior Cells.” This is like beating cancer at its own game. We believe it’s a modern day medical miracle. Of course, for early investors, this breakthrough could be just as miraculous. Here’s why…
PCD currently fights leukemia and lymphomas. But that’s just the beginning. Its unprecedented “seek and destroy” mechanism could soon radically improve a wide variety of cancer treatments… including Rituxan, Herceptin and many others. It could even treat autoimmune and inflammatory diseases, such as arthritis, asthma, even heart disease and multiple sclerosis.
In fact, estimates show that PCD and the technology behind it could dwarf the $5.6 billion in sales of the current top cancer treatment. Imagine discovering a gasoline that instantly doubled every car’s fuel mileage… or a computer chip that made every computer twice as fast. This is the kind of impact we’re expecting from PCD. And why we’re estimating early investors could see gains as high as 20 times their money. That’s “retire now” kind of gains – all from one easy move.
As Human Genome Sciences rolled out its breakthrough lupus treatment, its stock soared a stunning 5,891% over the surrounding 12-month period… Amgen share prices rocketed 1,113% in just over 2 years when it launched its Epogen red blood cell booster… And then there’s Biogen, which blasted up 1,439% in just over a year as its treatment for multiple sclerosis went mainstream… So what might happen to our tiny Maryland company? Take a quick look at the numbers… The “Big Four” cancer drugs right now treat several of the most commonly occurring cancers. Their combined sales are around $15 billion.
But sadly, they’re not always very effective. Considering the potential impact of PCD we expect it could soon hold a market share worth $7.5 billion. Even with a small 15% profit margin, earnings could come in around $112 billion, pricing this little $7 stock at more than $140 a share. Any way you cut it, you could be looking at a gain of about 2,000%… enough to turn just one grand into $20,000. Or put down $5,000 now and you could be sitting on a $100,000 windfall if this breakthrough follows the trajectory we’re predicting. And keep this in mind – the numbers could easily run higher, considering the magnitude of this revolution… After all, this past year alone in the fast moving biotech sector, we’ve seen gains such as 1,150% on Targacept, 1,541% on Jazz Pharmaceutical, 1,605% on Keryx Biopharm, and 1,843% on Human Genome Sciences. And right now, this situation is moving fast…
The news can’t stay out of the mainstream media much longer. In fact, just days ago we gained access to transcripts from a private conference call where a small group of clinical research experts discussed “PCD.” One researcher said:
Well, now you’re talking about a rare combination of conditions that can change lives… and make fortunes.
I have no doubt PCD will become one of the most important medical milestones of the 21st century. However I want to be completely frank here. PCD is NOT the “final and ultimate cure” for cancer. Sadly, we may not see that happen in our lifetime. But know this: PCD is perhaps the biggest cancer drug breakthrough to come along in our lifetimes. It has the potential to save 7.6 million lives a year. That’s more than America lost in the Civil War, WW I, WWII, Korea, Vietnam, and the Gulf COMBINED. Imagine the satisfaction knowing your personal fortune was generated by a treatment that ended pain and suffering for millions of people. This could bring you an enduring legacy of wealth to you, your children and even your grandchildren. And you don’t have to brag about it, or tell anyone you were a part of it… unless, of course, you choose to.
We’ve just completed our full research report on the tiny Maryland company that created “PCD.” It’s called: The “Smart Drug” Breakthrough That Can Turn $10,000 into $200,000. We’ll fill you in on exactly why their technology makes them uniquely poised for exponential growth… and how you can best position yourself to take advantage of this never-before opportunity. This company is on the threshold of starting a massive medical revolution… And when word gets out, your early investment now of just $1,000 could turn into as much as $20,000…. Or $10,000 into $200,000. That’s why fast action is critical. You’ll get all the intelligence about PCD in our new report, The “Smart Drug” Breakthrough That Can Turn $10,000 into $200,000. I’d like to rush this intelligence to you absolutely free, with my compliments. But before I go any further, let me first explain how I’m able to bring opportunities like this to reality for select individuals…
Each month, readers of our flagship investment research letter, The Money Map Report, receive a precise “road map” to making money. We show you where the big money surges are headed – from investment banks, governments, industry and private investors. And we regularly bring our readers special opportunities on breakthroughs like this “smart drug” that’s poised to make a few people extremely wealthy. When you can get ahead of a breakthrough like this smart drug – or other global shifts in the market – you can make money almost automatically. Just a few winners our experts have closed out in recent months include:
And our experts are currently showing readers open gains of…
Now they’re ready to hand YOU these same kind of recommendations as a Money Map Report subscriber. And this time around, thanks to the expected massive run-up in the PCD biotech, the gains are projected to be some of the biggest we’ve ever seen.
You won’t get rich taking advice from talking heads on cable news… or cub reporters writing for bankrupt newspapers. And that’s why we’re proud to have Money Map Report Chief Investment Strategist Keith Fitz-Gerald leading our seasoned Global Investing Team. Keith was one of the few professionals anywhere in the world to correctly call the dot-com collapse in 2000, the cyclical recovery in 2003, and the credit crisis in 2007 – a full year in advance. That call alone could have protected his readers from the collapse and made them a small fortune while everyone else was losing their shirts. He’s got one of the best-documented – and most accurate – predictive records in the business.
When Keith Fitz-Gerald talks, savvy investors listen. And when he provides them with his uniquely powerful investment research, they end up thanking him…
And that’s just a small sample of the hundreds of letters Keith gets each month.
Frankly, it’s not surprising, considering in the recent past we’ve brought our readers…
Each month in The Money Map Report, we include the simple, specific recommendations you’ll want to follow to pocket potential double and triple bagger gains in the coming weeks and months. As of this writing, our readers are seeing potential winners such as…
You’ll receive immediate access to our model portfolio once you join us. You’ll know exactly how to play each opportunity for maximum potential gains. And you’ll never have to worry about vague or confusing language. Because we provide detailed instructions on exactly when to buy, when to hold and when to sell. If that sounds like a good idea, then I urge you to try The Money Map Report right away. Just look what’s on the table as we speak…
“the Cisco of the smart grid” The emergence of the Internet two decades ago created a whole new kind of wealth. The best example might be Cisco Systems. The Internet-hardware company handed early investors 16,637% gains from 1990 to 2000. But some investors are poised to get even richer thanks to the emergence of a “New Internet.” Instead of handling emails and web pages, this network will route energy between power plants and customers in the most efficient way possible. Many call this new network the “Smart Grid.” and it will be 1,000 times bigger than the first, says a current Cisco Vice President. As CNET reports, the Smart Grid could add billions to the bottom lines of both utility companies and customers each year.
By increasing efficiency, the power companies will waste less energy and produce fewer emissions. No wonder Congress has approved $11 billion for the Smart Grid. And no wonder experts see the Smart Grid as a $100 billion market for new technologies, ideas and equipment. Here at the Money Map Press, we’ve discovered one rapidly emerging company that provides the data “hubs” for the Smart Grid. For investors in this small company – we call it the “Cisco of the Smart Grid” – this could mean enormous gains.
A Southern California Edison Vice President calls the hubs “an essential part of providing clean, cost-effective technology solutions to further enhance the reliability of the electric power grid.” And our “Cisco of the Smart Grid” company is just getting started. It’s looking at potential deals with dozens of other major metropolitan power companies. And as each new customer signs on, the company’s earnings will spark higher. Consider that the new Smart Grid promises to grow 1,000 times the size of the original Internet, you can see the profit potential. The gains could be positively Cisco-like. You’ll find all the details of this remarkable opportunity (and four more just like it) in our report “The Five Stocks That Can Ensure Your Retirement.” This report, as well as The “Smart Drug” Breakthrough That Can Turn $10,000 into $200,000 will also be given to you FREE of charge. To receive both free reports, all I ask in return is that you take a no-risk trial subscription to The Money Map Report. Here at The Money Map Report, we believe every individual deserves a chance to retire much richer thanks to his or her investments… instead of poorer. Even better… Let me show you what is in store for you…
from Europe’s “royal coffers”… forever
We’ve just come across the most potentially profitable income-producing investment you’ve likely never heard about. Your broker, CNBC, or the Wall Street Journal won’t clue you in on this, either. It’s virtually unknown outside the aristocratic circles of Europe’s elite blue bloods. You see, in 1857, Queen Isabella II of Spain decreed the creation of a “Royal Coffer.” By paying out money to Europe’s most powerful families on a regular basis, this “bottomless” cash supply would ensure that those families remained wealthy generation after generation. They’ve been tapping this bank’s vaults for centuries now, collecting money whenever needed. Now, The Money Map Report’s banking expert (and former U.S. Treasury advisor) Martin Hutchinson has found a completely legal way for U.S. citizens to collect from this same royal cash source – for the first time! One simple move can ensure that you too can pocket an extra $4,000 every month from now on… automatically. You’ll get all the details on how tap in to this mother lode with our special report How to Get Automatic Cash Payments Today. We’ll rush you this report right away, FREE of charge, when you take a trial subscription to The Money Map Report. That’s in addition to the The “Smart Drug” Breakthrough That Can Turn $10,000 into $200,000 and The Five Stocks that Can Ensure Your Retirement reports, which you’ll also get for free.
and quickly – from The Money Map Report
Your free reports will include every detail and instruction for pocketing substantial gains in the coming weeks and months. And that’s just the start… Every month you’ll get a stream of new recommendations and moneymaking ideas in The Money Map Report.
This confidential report is mailed and e-mailed to you each month to give you recommendations as fast as possible, so you can begin pocketing significant gains right away. You’ll also get flash e-mail updates on all of our recommended positions, along with trends, analysis and details on other special investing opportunities including…
I strongly encourage you to check out everything The Money Map Report has to offer right away.
And we think when you see the quality of recommendations you get, you would be very happy to pay the list price of just $99 per year. But we’re going to do better than that… Right now you can join us for – hold on to your hat – half price. That’s just $49.50 for a full year – a little over 13 cents a day. Imagine, just 13 cents a day. You can’t get a stick of gum for 13 cents. Investment and brokerage firms pay thousands of dollars every single month to get this kind of research and recommendations on a regular basis. And even at those high prices it’s worth it.
Yet it’s just simply our mission to help investors get ahead… and make the kind of money they need to live a worry-free lifestyle. We could charge more to fewer people, but that’s just not our goal. All for about 13 cents a day… And just one successful recommendation could earn you many times the cost of this research, even with the very first Report. The booming biotech alone could help you make 2,000% gains. That could be real cash you can take to the bank. Naturally, there are no guarantees these gains will happen, because no one can predict with 100% accuracy the future price of any stock. And the biotech sector can be volatile, with the government involved as it is… But make no mistake about it. This is a very serious opportunity that could have a profound impact on your personal wealth. At the Money Map Report we work hard to bring you the best opportunities, the most in-depth research, and the most thoughtful insights. Every month, in The Money Map Report I’ll show how you could make far more money than you would with “ordinary” investments… and with less risk and less work. Getting in early on this booming biotech breakthrough is just the first of many high-profit opportunities we’ll be rushing to you.
Go ahead and sign up right now – at half price. Grab all the extensive research reports I’ve mentioned:
Then, read the reports. Review the newsletter. Take a look at our performance. Decide if it’s right for you.
And if by some remote chance, you have any doubts… let me reassure you by making this 100% risk free on your part…
If for any reason you’re not overwhelmingly thrilled with our work… if you don’t immediately see us identifying one triple-digit winner after another… Then simply give us a call within the first 90 days – and you’ll receive a full refund, promptly and cheerfully. Either way, I insist you keep everything you’ve received up to that point just as our way of saying “thank you” for trying The Money Map Report… even if you cancel within 90 days and get every penny returned to you… The only side of the coin you’ll find is “Heads, you win!” That’s why our most important goal is to help you make a substantial amount of money in the days and weeks ahead. It’s time to secure your financial future Signing up for The Money Map Report is 100% hassle-free. Simply click below to fill out our safe and secure online acceptance form and we’ll rush you your Welcome Kit and free bonuses right away… with all the information you need to start seeing gains immediately.
But right now time is of the essence. The opportunities I’ve told you about are still “under the radar” of large institutions that invest billions and can run up the price fast. But they’re not likely to stay that way for long – especially once the media starts kicking in. That’s why it’s so important to act now. Take one simple step to ensure your wealth. It’s really that simple. Just click here now.
Or if you prefer to phone, just call (800) 585-0950 and mention Priority Code WMMRLA03. We’ll rush our Welcome Kit to you right away, and send you all your Special Reports immediately. But please, do it now. Every day means money in your pocket. Here’s to building a legacy of wealth. Sincerely, Mike Ward Publisher Let the Legacy Begin!
P.S. You’ll get all the information and research detailed above with your trial subscription to The Money Map Report. And remember, for a limited time, you’ll gain no-risk access to everything. And the cost to you is just pennies – around 13 cents a day. But please note: this special deal may end at any time. To get started simply click here, and we’ll take care of the rest. P.P.S. In recent days, the trading volume for the booming biotech stock has begun increasing. The company has already seen shares on the rise. You could be sitting big gains before Election Day. Don’t just read about this in the news. Use this behind-the-scenes intelligence now before the stock gaps up.
|
